|
Patient characteristics
|
|
Man gender (Male)
|
14 (56.00%)
|
48 (64.00%)
|
0.65 (0.21–2.00)
|
0.45
| | |
|
Age
|
63.48 ± 22.81
|
60.76 ± 19.01
|
1.01 (0.98–1.05)
|
0.36
| | |
|
Transferring from another hospital
|
10 (40.00%)
|
37 (49.33%)
|
0.92 (0.29–2.92)
|
0.88
| | |
|
Underlying diseases
|
|
PITT Scores
|
2.28 ± 1.86
|
2.98 ± 2.09
|
0.79 (0.54–1.15)
|
0.22
| | |
|
APACHE II Scores
|
17.16 ± 7.18
|
15.74 ± 8.13
|
1.10 (1.01–1.20)
|
0.05
|
0.40 (0.09–1.71)
|
0.22
|
|
Hypertension
|
13 (52.00%)
|
38 (50.66%)
|
0.62 (0.18–2.15)
|
0.42
| | |
|
Diabetes
|
12 (48.00%)
|
20 (26.67%)
|
3.97 (1.16–13.62)
|
0.03
|
4.30 (0.67–27.306)
|
0.12
|
|
Tuberculosis
|
2 (8.00%)
|
4 (5.33%)
|
0.94 (0.10–8.50)
|
0.95
| | |
|
Hepatitis B
|
2 (8.00%)
|
3 (4.00%)
|
2.17 (0.24–19.57)
|
0.09
| | |
|
Tumour
|
12 (48.00%)
|
21 (28.00%)
|
2.88 (0.85–9.72)
|
0.09
| | |
|
Respiratory diseases
|
17 (68.00%)
|
36 (48.00%)
|
2.64 (0.76–9.14)
|
0.13
| | |
|
COPD
|
9 (36.00%)
|
5 (6.67%)
|
0.92 (0.20–4.20)
|
0.91
| | |
|
Hepatobiliary disease
|
8 (32.00%)
|
26 (34.67%)
|
0.63 (0.18–2.10)
|
0.47
| | |
|
Gastrointestinal disease
|
6 (24.00%)
|
27 (36.00%)
|
0.36 (0.09–1.46)
|
0.15
| | |
|
Chronic kidney disease
|
6 (24.00%)
|
21 (28.00%)
|
0.75 (0.21–2.70)
|
0.66
| | |
|
Urinary system disease
|
10 (40.00%)
|
6 (8.00%)
|
7.71 (2.21–26.83)
|
0.001
|
18.06 (3.31–98.62)
|
0.001
|
|
Cardiovascular disease
|
15 (60.00%)
|
41 (54.67%)
|
0.87 (0.27–2.80)
|
0.82
| | |
|
Coronary heart disease
|
7 (28.00%)
|
10 (13.33%)
|
4.26 (1.12–16.28)
|
0.03
|
3.29 (0.91–11.98)
|
0.07
|
|
Neurological disease
|
9 (36.00%)
|
18 (24.00%)
|
2.27 (0.64–7.99)
|
0.20
| | |
|
Disease of immune system
|
1 (4.00%)
|
5 (6.67%)
|
0.22 (0.02–2.85)
|
0.25
| | |
|
Hematological system diseases
|
4 (16.00%)
|
16 (21.33%)
|
1.47 (0.32–6.72)
|
0.62
| | |
|
Endocrine System Diseases
|
15 (60.00%)
|
28 (37.33%)
|
3.16 (1.05–9.54)
|
0.04
|
1.62 (0.33–7.99)
|
0.55
|
|
Surgery in the past 6 months
|
2 (8.00%)
|
16 (21.33%)
|
0.32 (0.05–1.99)
|
0.22
| | |
|
Multiple organ dysfunction syndrome
|
6 (24.00%)
|
8 (10.67%)
|
6.27 (1.35–29.05)
|
0.02
| | |
|
Transplant
|
4 (16.00%)
|
11 (14.67%)
|
1.82 (0.43–7.64)
|
0.42
| | |
|
Urinary tract infection
|
10 (40.00%)
|
12 (16.00%)
|
3.64 (0.78–16.87)
|
0.09
| | |
|
Respiratory infection
|
21 (84.00%)
|
51 (68.00%)
|
2.20 (0.37–12.92)
|
0.38
| | |
|
Abdominal infection
|
8 (32.00%)
|
2 (2.67%)
|
0.48 (0.05–4.68)
|
0.53
| | |
|
Septic shock
|
1 (4.00%)
|
9 (12.00%)
|
0.99 (0.95–1.02)
|
0.53
| | |
|
Severe anemia
|
5 (20.00%)
|
17 (26.15%)
|
1.06 (0.27–4.13)
|
0.94
| | |
|
Glucocorticoid
|
7 (28.00%)
|
12 (16.00%)
|
2.58 (0.86–9.72)
|
0.21
| | |
|
Cardiotonic
|
2 (8.00%)
|
5 (6.67%)
|
0.78 (0.08–7.87)
|
0.84
| | |
|
Receipt of total parenteral Nutrition (days)
|
39.00 ± 57.47
|
16.71 ± 25.33
|
0.99 (0.95–1.02)
|
0.53
| | |
|
Urinary catheter (days)
|
56.08 ± 60.35
|
21.80 ± 26.07
|
1.04 (0.99–1.09)
|
0.08
| | |
|
Nasal catheter (days)
|
35.38 ± 48.75
|
21.59 ± 36.98
|
0.97 (0.92–1.04)
|
0.16
| | |
|
Mechanical ventilation (days)
|
34.64 ± 48.61
|
15.15 ± 19.01
|
1.02 (0.98–1.09)
|
0.16
| | |
|
Trachea cannula
|
24.80 ± 48.02
|
12.65 ± 24.27
|
0.98 (0.95–1.03)
|
0.55
| | |
|
Tracheotomy
|
10 (40.00%)
|
31 (41.33%)
|
0.17 (0.02–1.28)
|
0.08
| | |
|
Bronchoscopy
|
12 (48.00%)
|
13 (17.33%)
|
8.15 (1.61–41.22)
|
0.01
|
4.05 (1.30–12.60)
|
0.01
|
|
Drainage tube
|
19 (76.00%)
|
55 (73.33%)
|
0.31 (0.05–1.76)
|
0.18
| | |
|
Penicillin
|
5 (20.00%)
|
17 (22.67%)
|
0.60 (0.14–2.55)
|
0.48
| | |
|
Cephalosporins
|
8 (32.00%)
|
25 (33.33%)
|
0.37 (0.08–1.61)
|
0.19
| | |
|
Carbapenem
|
10 (40.00%)
|
24 (32.00%)
|
1.12 (0.32–3.84)
|
0.86
| | |
|
Fluoroquinolone
|
5 (20.00%)
|
11 (14.67%)
|
0.87 (018–4.30)
|
0.87
| | |
|
Tetracycline
|
3 (12.00%)
|
4 (5.33%)
|
0.93 (0.14–5.90)
|
0.92
| | |
|
Glycopeptide
|
3 (12.00%)
|
12 (16.00%)
|
0.20 (0.03–1.15)
|
0.07
| | |
|
Tigecycline
|
4 (16.00%)
|
3 (4.00%)
|
1.94 (0.27–13.98)
|
0.51
| | |
|
Combined use of antibiotics
|
18 (72.00%)
|
32 (42.67%)
|
5.91 (1.20–29.16)
|
0.03
|
3.60 (1.18–10.93)
|
0.02
|
